“Although the initial focus is on colorectal cancer detection and prevention, the company's robust platform has the potential to address a broad range of unmet needs in managing gastrointestinal conditions,” said the new CMO.

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.